1Mayser P,Haze P,Papavassilis C,et al. Differentiation of Malassezia species: selectivity of cremophor EL, castor oil and ricinoleic acid for M.furfur[J]. Br J Dermatol, 1977,137(2):208-213.
2Mittag H.Morphology of Malassezia-associated diseases[J]. Mycoses, 1996,39(suppl 1):13-19.
3Mayser P, Gross A. IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens[J]. Acta Derm Venereol,2000,80(5):357-361.
2Stefanaki I, Katsambas A. Therapeutic update on seborrheic dermatitis[J]. Skin Therapy Lett, 2010,15 (5) .- 1-4.
3Crutchfield C E 3rd,Lewis E J, Zelickson B D. The highly ef- fective use of topical zinc pyrithione in the treatment of psoria- sis : a case report[J]. Dermatol Online J, 1997,3 (1) ： 3.
4Mills K J, Hu P, Henry J, et al. Dandruff/seborrhoeic dermati- tis is characterized by an inflammatory genomic signature and possible immune dysfunction: transcriptional analysis of the condition and treatment effects of zinc pyrithione[J]. Br J Der- matol, 2012,166 (S 2) : 33-40.
